Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients-Reference-Cited by-同舟云学术

Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients

Published:2020-06 Issue: Volume:178 Page:104746
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Dou Yingying,Jansen Diahann T.S.L.,van den Bosch Aniek,de Man Robert A.,van Montfoort Nadine,Araman Can,van Kasteren Sander I.,Zom Gijs G.,Krebber Willem-Jan,Melief Cornelis J.M.,Woltman Andrea M.,Buschow Sonja I.

Funder

NWO

Dutch Research Council, the Netherlands

Dutch Ministry of Economic Affairs, the Netherlands

Ministry of Economic Affairs

Dutch Digestive Foundation

ISA Pharmaceuticals B.V. Leiden, the Netherlands

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference42 articles.

1. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection;Bertoletti;Gut,2011

2. Adaptive immunity in HBV infection;Bertoletti;J. Hepatol.,2016

3. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein;Bertoletti;J. Virol.,1993

4. Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation;Bijker;Eur. J. Immunol.,2008

5. CD4+ T cell help in cancer immunology and immunotherapy;Borst;Nat. Rev. Immunol.,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells;JHEP Reports;2024-05

2. Sec22b and Stx4 Depletion Has No Major Effect on Cross-Presentation of PLGA Microsphere–Encapsulated Antigen and a Synthetic Long Peptide In Vitro;The Journal of Immunology;2023-08-28

3. Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides;Cancer Immunology, Immunotherapy;2023-05-24

4. Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus;Antiviral Research;2023-01

5. Contribution of T- and B-cell intrinsic toll-like receptors to the adaptive immune response in viral infectious diseases;Cellular and Molecular Life Sciences;2022-10-12